Dergiler / Medicine Science / 2015 / Cilt: 4 - Sayı: 3

Hemostasis, Disorders of Coagulation and Transfusion in Cirrhosis

Sayfa
2610–2649
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Newer modalities like thromboelastography and thrombography have helped in making point of care reliable by improving assessment of coagulation processes globally and further studies and evidence point towards imparting a much better knowledge into this complex situation that is hemostasis/coagulation and liver disease

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Coagulation disorders in liver diseases, especially cirrhosis occurs due to a complex play between procoagulant and anticoagulant factors.
📊
Temel Bulgular & Veri:Multiple factors such as portal hypertension, decreased thrombopoetin production, endothelial dysfunction and thrombocytopenia and thrombocytopathy in cirrhosis pave way for coagulation abnormalities in this group of patients.
💡
Sonuç & Katkı:Newer modalities like thromboelastography and thrombography have helped in making point of care reliable by improving assessment of coagulation processes globally and further studies and evidence point towards imparting a much better knowledge into this complex situation that is hemostasis/coagulation and liver disease
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Coagulation disorders in liver diseases, especially cirrhosis occurs due to a complex play between procoagulant and anticoagulant factors. The understanding of bleeding and thrombosis in liver disease is fundamental to management and diagnosis of both these conditions that can occur in liver cirrhosis. In contrast to earlier teaching that considered cirrhosis to be an ‘auto anticoagulated’ state, the current approach to considering it as a state of ‘rebalanced hemostasis’ which can tip to either bleeding profile or thrombotic profile in the same patient has made way to considerable improvements in management and diagnosis of hemostatic and coagulation abnormalities in cirrhosis patients. The liver plays a central role in the four phases of clotting which includes platelet plug initiation and formation, coagulation cascade activity, clotting termination and clot removal by fibrinolysis. Multiple factors such as portal hypertension, decreased thrombopoetin production, endothelial dysfunction and thrombocytopenia and thrombocytopathy in cirrhosis pave way for coagulation abnormalities in this group of patients. Newer modalities like thromboelastography and thrombography have helped in making point of care reliable by improving assessment of coagulation processes globally and further studies and evidence point towards imparting a much better knowledge into this complex situation that is hemostasis/coagulation and liver disease

🔖

Bu Makaleye Atıf Yap

PHİLİPS, A. C. A., MUKHOPADHYAY, P. (2015). Hemostasis, Disorders of Coagulation and Transfusion in Cirrhosis. Medicine Science, Cilt: 4 - Sayı: 3, 2610–2649. https://ajindex.com/articles/277691

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147-156
  2. Tripodi A. Hemostasis in chronic liver disease. J Thromb Haemost. 2006;4(9):2064- 65
  3. Pradella P, Bonetto S, Turchetto S, Uxa L, Comar C, Zorat F, De Angelis V, Pozzato G. Platelet production and destruction in liver cirrhosis. J Hepatol. 2011;54(5):894- 900
  4. Armando T, Veena C, Massimo P, Federica F, Alessandra D, Cinzia S, Pier Mannuccio M. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation. Hepatology. 2007;46(2):520-27
  5. Tripodi A, Primignani M, Mannucci PM. Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged. Intern Emerg Med. 2010;5(1):7-12
  6. Colucci, M., Binetti, B. M., Branca, M. G., Clerici, C., Morelli, A., Semeraro, N. and Gresele, P. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis. Hepatology. 2003;38(1):230-7
  7. Armando Tripodi, Massimo Primignani, Laura Lemma, Veena Chantarangkul, Pier Mannuccio Mannucci. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis, Journal of Hepatology. 2013;59(2);265-70
  8. Kajihara M, Okazaki Y, Kato S, Ishii H, Kawakami Y, Ikeda Y, Kuwana M. Evaluation of platelet kinetics in patients with liver cirrhosis: similarity to idiopathic thrombocytopenic purpura. J Gastroenterol Hepatol. 2007;22(1):112-8
  9. Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol. 2011;55(6):1415-27
  10. Ordinas A, Escolar G, Cirera I, Viñas M, Cobo F, Bosch J, Terés J, Rodés J., Existence of a platelet-adhesion defect in patients with cirrhosis independent of hematocrit: studies under flow conditions. Hepatology. 1996;24(5):1137-42
  11. Sayed D, Amin NF, Galal GM. Monocyte-platelet aggregates and platelet micro particles in patients with post-hepatitic liver cirrhosis. Thromb Res. 2010;125(5):228- 33
  12. Tripodi A, Primignani M, Chantarangkul V, Clerici M, Dell'Era A, Fabris F, Salerno F, Mannucci PM. Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology. 2006;44(2):440-5
  13. Caldwell SH., Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, Tripodi A, Sanyal AJ. Coagulation disorders and hemostasis in liver disease: Pathophysiology